Literature DB >> 18437683

Prognostic significance of nuclear and cytoplasmic expression of metallothioneins as related to proliferative activity in squamous cell carcinomas of oral cavity.

Jolanta Szelachowska1, Piotr Dziegiel, Joanna Jelen-Krzeszewska, Michal Jelen, Radoslaw Tarkowski, Iwona Wlodarska, Barbara Spytkowska, Iwona Gisterek, Rafal Matkowski, Jan Kornafel.   

Abstract

UNLABELLED: Metallothioneins (MT) are low molecular weight proteins with high metal and cystein contents. This study was designed to test the hypothesis that cytoplasmic and nuclear MT expression are of prognostic importance in patients with squamous cell carcinomas of the oral cavity, treated by surgery with subsequent radiotherapy. The second aim of the study was to test the potential correlation between the nuclear and cytoplasmic MT expressions as compared to expression of proliferation markers and other clinicopathological variables.
MATERIAL AND METHODS: The studies were performed on tumor samples from 50 patients with diagnosis of squamous cell carcinoma of the oral cavity floor or of oral part of the tongue. All the patients were subjected to radical surgery, accompanied by removal of lymph nodes and post-operative radiotherapy.
RESULTS: No significant correlation could be detected between percentage and intensity of MT expression on one hand and proportions of cells with Mcm-2 (minichromosome maintenance protein 2), Ki-67 expressions, nor the grade of malignancy (G) on the other. A significantly shorter survival was detected among patients with tumors of MT expression rated 9 or 12 according to the Remmele scale and among patients with a high percentage (> 50%) of nuclear MT staining. In mulivariate analyses, only OTT (Overall Treatment Time), lymph node involvement and high expression of Mcm-2 were found to be independent risk factors for decreased patient's survival.
CONCLUSION: This is relevant evidence that MT overexpression could be related to worse prognosis in patients with oral cancer. We have found no relationship between MT expression and proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437683     DOI: 10.14670/HH-23.843

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  4 in total

1.  Immunoexpression of Metallothionein in Oral Squamous Cell Carcinoma.

Authors:  Rakesh Kumar Dumpala; Venkateswara Rao Guttikonda
Journal:  J Maxillofac Oral Surg       Date:  2015-03-18

2.  Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.

Authors:  Aleksandra Zamirska; Łukasz Matusiak; Piotr Dziegiel; Grażyna Szybejko-Machaj; Jacek C Szepietowski
Journal:  Pathol Oncol Res       Date:  2012-03-10       Impact factor: 3.201

3.  Role of metallothioneins in benign and malignant thyroid lesions.

Authors:  Bartosz Pula; Pawel Domoslawski; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Thyroid Res       Date:  2012-12-28

4.  Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour.

Authors:  Aline-Cristina-Batista-Rodrigues Johann; Patrícia-Carlos Caldeira; Marcelo-Vidigal Caliari; Ricardo-Santiago Gomez; Maria-Cássia-Ferreira Aguiar; Ricardo-Alves Mesquita
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.